financetom
Business
financetom
/
Business
/
--Tesla Chief Information Officer Nagesh Saldi is Leaving, Bloomberg Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Tesla Chief Information Officer Nagesh Saldi is Leaving, Bloomberg Reports
Oct 3, 2024 10:08 AM

12:39 PM EDT, 10/03/2024 (MT Newswires) --

Price: 242.54, Change: -6.48, Percent Change: -2.60

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canterbury Park Q3 revenue drops as casino activity weakens
Canterbury Park Q3 revenue drops as casino activity weakens
Nov 6, 2025
Overview * Canterbury Park ( CPHC ) Q3 revenue falls 5% yr/yr, impacted by reduced casino revenues * Net income for Q3 declines significantly, impacted by prior year land transfer gain * Adjusted EBITDA for Q3 decreases, reflecting lower casino revenue and stable expenses Outlook * Company did not provide specific financial guidance for future quarters or full year Result...
Pliant Therapeutics Q3 net loss narrows to $26.3 mln
Pliant Therapeutics Q3 net loss narrows to $26.3 mln
Nov 6, 2025
Overview * Pliant Q3 net loss narrows to $26.3 mln, driven by BEACON-IPF discontinuation * Company completed voluntary prepayment of Oxford Finance loan Outlook * BEACON-IPF close out activities to be completed in Q4 2025 Result Drivers * R&D EXPENSES - Decrease primarily due to discontinuation of BEACON-IPF trial * ADMINISTRATIVE COSTS - Decline due to strategic workforce restructuring Key...
Trisura Group Q3 Operating Earnings Meets Forecast
Trisura Group Q3 Operating Earnings Meets Forecast
Nov 6, 2025
04:53 PM EST, 11/06/2025 (MT Newswires) -- Trisura Group ( TRRSF ) Thursday after-trade reported higher third-quarter operating earnings that met forecasts. The specialty insurer said operating net income rose 3.6% to $34.4 million, or $0.71 per share, from $33.2 million, or $0.68, in the prior-year period. The improvement was due to profitable underwriting and growth in net investment income....
Protagonist Therapeutics Q3 net loss widens to $39.3 mln
Protagonist Therapeutics Q3 net loss widens to $39.3 mln
Nov 6, 2025
Overview * Protagonist Therapeutics ( PTGX ) reports Q3 net loss of $39.3 mln, increased R&D expenses noted * Cash reserves of $678.8 mln expected to sustain operations through 2028 * NDA for icotrokinra submitted to FDA, rusfertide gets breakthrough designation Outlook * Protagonist expects rusfertide NDA filing by end of 2025 * Company anticipates PN-477sc clinical study initiation by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved